Prognostic significance of opioid use in the active treatment of advanced colorectal cancer

Inoue,Yasuhiro; Iwata,Takashi; Okugawa,Yoshinaga; Kawamoto,Aya; Hiro,Junichiro; Toiyama,Yuji; Tanaka,Koji; Uchida,Keiichi; Mohri,Yasuhiko; Kusunoki,Masato

doi:10.3892/mco.2012.16

January-February 2013 Volume 1 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-February 2013 Volume 1 Issue 1

Full Size Image

Article

Prognostic significance of opioid use in the active treatment of advanced colorectal cancer

Authors:
- Yasuhiro Inoue
- Takashi Iwata
- Yoshinaga Okugawa
- Aya Kawamoto
- Junichiro Hiro
- Yuji Toiyama
- Koji Tanaka
- Keiichi Uchida
- Yasuhiko Mohri
- Masato Kusunoki
View Affiliations / Copyright

Affiliations: Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan
Pages: 59-64
|
Published online on: August 31, 2012

https://doi.org/10.3892/mco.2012.16
Expand metrics +

Abstract

This study aimed to evaluate the oncologic significance of opioid use during active treatment for advanced colorectal cancer (CRC). The patients included in this study underwent therapeutic chemotherapy for metastatic and/or recurrent CRC. The primary outcomes measured were the characteristics of CRC patients who were administered opioid to maintain compliance with cancer treatments as well as the impact of opioid use on cancer‑specific survival. Of the 245 patients, 117 (48%) were administered opioid during chemotherapy. No significant associations were detected between opioid use and clinicopathological factors, with the exception of age (<65 or ≥65 years; P=0.0281), pathology (differentiated or undifferentiated; P=0.0007) and response rate to chemotherapy (P=0.0056). Patients administered opioid had significantly poorer cancer‑specific survival compared to patients who did not receive opioid. The mean cancer‑specific survival periods were 606±57 days (chemotherapy with opioid), <636±46 days (chemotherapy without opioid), <1140±95 days (multimodal therapy with opioid) and <1556±160 days (multimodal therapy without opioid). Additionally, oncologic emergencies due to cancer progression were significantly correlated with opioid use (P=0.0002), although no statistically significant differences were detected between the cancer‑specific survival period and oncologic emergencies. The use of opioid to maintain compliance with active cancer therapy is advised in modern CRC management. However, CRC patients that were administered opioid may have potential progressive disease, thus clinicians need to be aware of the oncologic emergencies possibly arising during an active CRC therapy.

View Figures

View References

1.	Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 350:2335–2342. 2004.
2.	Van Cutsem E, Köhne CH, Hitre E, et al: Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 360:1408–1417. 2009.
3.	Fuchs CS, Marshall J, Mitchell E, et al: Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C study. J Clin Oncol. 25:4779–4786. 2007.
4.	Brown J, Thorpe H, Napp V, et al: Assessment of quality of life in the supportive care setting of the big lung trial in non-small cell lung cancer. J Clin Oncol. 23:7417–7427. 2005.
5.	Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ. 311:899–909. 1995.
6.	Spiro SG, Rudd RM, Souhami RL, et al: Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax. 59:828–836. 2004.
7.	Temel JS, Greer JA, Muzikansky A, et al: Early palliative care for patients with metastatic non-small cell lung cancer. N Engl J Med. 363:733–742. 2010.
8.	American Pain Society: Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 5th edition. American Pain Society; Glenview, IL: 2003
9.	Inoue Y, Hiro J, Toiyama Y, et al: Optimal use of current chemotherapy in multimodality therapy for advanced colorectal cancer. Oncol Lett. 3:363–368. 2012.
10.	Kusunoki M, Noda M, Yanagi H, et al: Second-look hepatectomy after 5-FU arterial infusion in patients with primary unresectable hepatic colorectal metastases. Int J Oncol. 10:107–111. 1997.
11.	Lennon FE, Moss J and Singleton PA: The μ-opioid receptor in cancer progression: is there a direct effect? Anesthesiology. 116:940–945. 2012.
12.	Mathew B, Lennon FE, Siegler J, et al: The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg. 112:558–567. 2011.
13.	Nylund G, Pettersson A, Bengtsson C, et al: Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon. Dig Dis Sci. 53:461–466. 2008.
14.	Lennon FE, Mirzapoiazova T, Mambetsariev B, et al: Over-expression of the μ-opioid receptor in human non-small cell lung cancer promotes akt and mTOR activation, tumor growth, and metastasis. Anesthesiology. 116:857–867. 2012.
15.	Smith TJ, Temin S, Alesi ER, et al: American society of clinical oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 30:880–887. 2012.
16.	Greer JA, Pirl WF, Jackson VA, et al: Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small cell lung cancer. J Clin Oncol. 30:394–400. 2012.
17.	Zenda S, Matsuura K, Tachibana H, et al: Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy. Radiother Oncol. 101:410–414. 2011.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Prognostic significance of opioid use in the active treatment of advanced colorectal cancer

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles